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GUIDE FOR AUTHORS
Value in Health Regional Issues is a peer-reviewed publication of the Inter-
national Society for Pharmacoeconomics and Outcomes Research, focus-
ing on Asia, Latin American, Central & Eastern Europe, Western Asia, and
Africa. Its mission is to provide a forum for the advancement and dissemi-
nation of knowledge and research in pharmacoeconomics and the health-
related outcomes of disease and treatment processes, and therefore so-
licits original contributions in health care policty analysis, outcomes
research (clinical, economic, and patient-reported) empirical studies, meth-
odological studies, and manuscripts on health care resources in the region.
Health care decision-maker commentaries from health outcomes research-
ers and policy makers are welcome. Commentaries are expected to include
discussion on how researchers can better respond to the needs of those
making clinical and financial decisions in health care.
Value in Health Regional Issues does not consider papers reporting
data series or data sets that do not include appropriate statistical
confidence intervals and/or other measures of statistical imprecision.
Value in Health Regional Issues also does not consider papers reporting
modeling results that do not include sensitivity analysis of key and
influential model parameters.
Authors for whom English is a second language that would like to
submit a manuscript in English may choose to have their manuscript
professionally edited before submisstion or during the review process.
Authors wishing to employ a professional English-language editing ser-
vice (English manuscript submissions only) should make contact and
arrange payment with the editing service of their choice. For more
details regarding the recommended services, see http://support.
elsevier.com/.
Value in Health Regional Issues articles may be published in a language
of the region other than English (i.e. Chinese, Korean, Japanese, Thai,
Indonesian, etc. for Asia; Spanish, Portuguese, etc. for Latin America;
and Russian, Polish, Arabic, etc. for Central & Eastern Europe, Western
Asia and African region). All manuscripts accepted for publication in
Value in Health Regional Issues must have an abstract and key-
words in English as well as the language of the manuscript (if not
English). Languages for a specific issue are decided by the Value in
Health Regional Issues Editorial Board.
The criteria for a manuscript to be considered for Value in Health
Regional Issues are as follows:
● First author must reside in the region to which a specific regional
issue is dedicated; and
● The empirical study manuscript submitted to Value in Health Re-
gional Issues must include subjects from population(s) in the region
to which a specific regional issue is dedicated.
For further details concerning the types of articles and eligible regions
suitable for Value in Health Regional Issues, see: http://www.ispor.org/
publications/VIHRI/VIHRImain.asp.
I. ETHICS IN PUBLISHING
For information on Ethics in Publishing and Ethical guidelines for journal
publication see http://www.elsevier.com/publishingethics and http://
www.elsevier.com/ethicalguidelines.
II. CONFLICT OF INTEREST
All authors must disclose any financial and personal relationships with
other people or organizations that could inappropriately influence (bias)
their work. Examples of potential conflicts of interest include employ-
ment, consultancies, stock ownership, honoraria, paid expert testimony,
patent applications/registrations, and grants or other funding. See also
http://www.elsevier.com/conflictsofinterest.
III. SUBMISSION DECLARATION
Submission of an manuscript implies that the work described has not
been published previously (except in the form of an abstract or as part
of a published lecture or academic thesis), that it is not under consider-
ation for publication elsewhere, that its publication is approved by all
authors and tacitly or explicitly by the responsible authorities where the
work was carried out, and that, if accepted, it will not be published
elsewhere including electronically in the same form, in English or in any
other language, without the written consent of the copyright-holder.
IV. RETAINED AUTHOR RIGHTS
As an author you (or your employer or institution) retain certain rights; for
details please refer to: http://www.elsevier.com/authorsrights.
V. FUNDING BODY AGREEMENTS AND POLICIES
Elsevier has established agreements and developed policies to allow
authors whose articles appear in journals published by Elsevier, to
comply with potential manuscript archiving requirements as specified as
conditions of their grant awards. To learn more about existing agree-
ments and policies please visit http://www.elsevier.com/fundingbodies.
VI. MANUSCRIPT SUBMISSION AND SPECIFICATIONS
Submissions received eight months prior to the publication date will be
considered by the upcoming issue. Publication timeline for a specific
regional issue is below:
● Value in Health Regional Issues for Asia is published in May.
● Value in Health Regional Issues for Central & Eastern Europe,
Western Asia and Africa is published in August.
● Value in Health Regional Issues for Latin America is published in
December.
To submit a manuscript to Value in Health Regional Issues, please go to:
http://www.ispor.org/publications/VIHRI/submission_instruction.asp. For
assistance, authors may contact the Value in Health Regional Issues
editorial office at: vihri@ispor.org.
If submissions are larger than 500 KB, they should be compressed
using PKZIP or WINZIP.
Authors will be required to assign copyright of their papers. Copyright
assignment is a condition of publication and papers will not be passed to
the publisher for production unless copyright has been assigned. An
appropriate copyright assignment form can be found at the following
address: http://www.ispor.org/publications/VIHRI/submission_instruction.asp.
A faxed copy of this completed and signed form is acceptable; fax to 609-586-
4982 or email to: vihri@ispor.org.
If excerpts from other copyrighted works are included, the author(s)
must obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by authors
in these cases: please consult: http://www.elsevier.com/permissions.
Each Submission should contain separate documents as follows:
i. COVER LETTER. The cover letter should include: 1) title of the man-
uscript; 2) name of the document file(s) containing the manuscript and the
software (and version) used; 3) name and all contact information for the
corresponding author and a statement as to whether the data, models, or
methodology used in the research are proprietary; 4) names of all spon-
sors of the research and a statement of all direct or indirect financial
relationships the authors have with the sponsors; and 5) if applicable, a
statement that the publication of study results was not contingent on the
sponsor’s approval or censorship of the manuscript.
For a sample cover letter, see:
http://www.ispor.org/publications/VIHRI/SampleCoverLetter.doc.
ii. TITLE PAGE. The title page should contain the following: 1) title; 2) full
names (first and surname) of all authors including academic degrees and
affiliation(s); 3) name, mailing and email addresses, telephone and fax num-
bers of corresponding author (with whom all correspondence will take place
unless other arrangements are made); 4) all sources of financial or other
support for the manuscript (if no funding was received, this should be noted
on the title page); 5) at least four key words for indexing purposes; and 6) a
running title of not more than 45 characters including spaces.
For a sample title page, see:
http://www.ispor.org/publications/VIHRI/SampleTitlePg.doc.
iii. MANUSCRIPTS. Manuscripts must be typed in either Microsoft Word
(Version 5.0 or later) or WordPerfect (version 5.1 or later). Manuscripts
should be in 8.5x11-inch page format, double-spaced with 1-inch margins on
all sides and size 10 font (Arial or Times New Roman fonts are preferred).
Minimal formatting should be used, i.e., no justification, italics, bold, indenting,
etc. There should be no hard returns at the end of lines. Double-spacing after
each element is requested (e.g., headings, titles, paragraphs, legends). The
‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals’
should be consulted for specific style issues not addressed here
(www.acponline.org, Ann Intern Med 1997;126:36-47). The word count
should be less than 4500.
a.ABSTRACT.An abstract of 250words or less is required, summarizing
the work reported in themanuscript. Original researchmanuscripts should
use a structured format for the abstract, i.e., Objectives, Methods, Re-
sults, Conclusions. A non-English researchmanuscript requires an abstract
in English as well as in the language of the manuscript.
b. TEXT. The body of the manuscript should be divided into sections that
facilitate reading and comprehension of the material. This should normally
include sections with the major headings: Introduction, Methods, Results,
Conclusions, Acknowledgments (if needed), and References. There should
be no footnotes. Figures (inclusive of figure legends) and Tables must be
submitted each as separate documents.
c. REFERENCES. References should be listed in a separate section and
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numbered consecutively with Arabic numerals in the order in which
they are cited in the text. Citing unpublished or non-peer-reviewed
work such as abstracts and presented papers is discouraged.
Personal communications may be indicated in the text as long as
written acknowledgment from the authors of the communications
accompanies the manuscript. Reference style should follow that of
Index Medicus. Spell out single-word journals and abbreviate all others
according to the style of Index Medicus. If there are more than four
authors, use only the names of the first three, followed by et al.
The three most common types of references are illustrated
below for example.
Journal article: Surname and initials of author(s), title of article, name
of journal, year, volume number, first and last page.
Arocho R, McMillan CA. Discriminant and criterion evaluation of the
U.S.-Spanish version of the SF-36 Health Survey in a Cuban-American
population with benign hyperplasia. Med Care 1998;36:766–72.
Book: Surname and initials of author(s)/editor(s), title and subtitle,
volume, edition (other than first), city, publisher, year.
Johnston J. Econometric Methods (3rd ed.). New York: McGraw-Hill,
1984.
Chapter in Book: Surname and initials of author(s), title of chapter,
author(s)/editor(s) of book, title of book, volume, edition (other than
first), city, publisher, year.
Luce BR, Manning WG, Siegel JE, et al. Estimating costs in cost-
effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, et al., eds.,
Cost-effectiveness in Health and Medicine. New York: Oxford University
Press, 1996.
Website: Title of article on web. WWW.Document. Available from:
http://www... [Assessed Month Day, Year].
International Society for Pharmacoeconomics and Outcomes Re-
search (ISPOR) Good Outcomes Research Practices Index. Avail-
able from: http://www.ispor.org/workpaper/practices_index-
.asp. [Accessed January 1, 2011].
For a sample manuscript, see:
http://www.ispor.org/publications/VIHRI/SampleManuscript.pdf.
iv. TABLES. Tables should be clearly labeled, neatly typed, and easy to
understand without reference to the text. Each should be double-spaced
and presented on a separate page. Statistical estimates should indicate
parameter estimates and, as appropriate, t ratios or standard error,
statistical significance, sample size, and other relevant information. All
abbreviations must be explained below each table. Each table should be
numbered and have a self-explanatory title.
For a sample table, see:
http://www.ispor.org/publications/VIHRI/SampleTbls.doc.
v. FIGURES. Figures should each be submitted as a separate image file,
not embedded in the manuscript document or in a slide presentation. Cite
figures consecutively, as they appear in the text, with Arabic numbers
(Figure 1, Figure 2, Figure 3A, etc.). If, together with your accepted
manuscript, you submit usable color figures then the Journal will ensure,
at no additional charge that these figures will appear in color on the Web
(e.g., ScienceDirect and other sites) regardless of whether or not these
illustrations are reproduced in color in the printed version. There will be a
charge for color reproduction in print; you will receive information regard-
ing the costs from Elsevier after receipt of your accepted manuscript.
Please indicate your preference for color in print or on the Web only. Each
figure must be assigned a brief title (as few words as possible, and
reserving abbreviations for the legend) as well as a legend. The corre-
sponding legend should be typed double-spaced on a separate page. All
symbols, arrows, and abbreviations must be explained in the legend.
Please submit files with a resolution of at least 300 DPI. Line artwork
should contain a resolution of least 1000 DPI. Elsevier recommends
submitting figures in the following formats: TIFF, JPG, EPS, and PDF.
Please be sure to delete any identifying patient information such as name,
social security number, etc. Photographs in which a person’s face is
recognizable must be accompanied by a letter of release from that
person explicitly granting permission for publication in the Journal. For any
previously published material, written permission for both print and elec-
tronic reprint rights must be obtained from the copyright holder. For
further explanation and examples of artwork preparation, see Elsevier’s
Author Artwork Instructions at www.elsevier.com/artwork.
For a sample figure, see:
http://www.ispor.org/publications/VIHRI/SampleFigure.doc.
vi. SUPPLEMENTAL MATERIAL OR SUPPLEMENTAL DATA. You
may submit appendixes that describe either methods or results in more
detail if these are needed for clarity of understanding by either peer
reviewers or readers. If appropriate, materials suitable for Web publica-
tion but not print publication (eg, audio or video files, see below) can also
be submitted. If you do so, indicate the particular reasons for the appen-
dix and whether you are submitting it for possible Web publication or
simply for peer review purposes. Value in Health Regional Issues accepts
audio and video files as ancillaries to the main article. Audio files should
be in .mp3 format; the recommended upper limit for the size of a single
file is 10 Mb. Video files should be submitted in .mpg or .mp4 format, the
recommended upper limit for the size of a single file is 10 Mb. Any
alternative format supplied may be subject to conversion (if technically
possible) prior to online publication.
vii. SURVEY INSTRUMENT. For papers analyzing preferences, Value in
Health Regional Issues requires the submission of a copy of the survey
instrument used to generate the preference data. This is to help in the
review process and the survey instrument need not appear in a final
publication. If the authors wish the questionnaire to be published with the
paper, it should be submitted as part of the paper. If they do not wish it
to be published, it should be submitted as Supporting Information and
then will be sent to the reviewers as a reviewer’s appendix.
VII. DATA, MODELS, AND METHODOLOGY
All authors must agree to make their data available at the Editor’s
request for examination and re-analysis by referees or other persons
designated by the Editor. All models and methodologies must be pre-
sented in sufficient detail to be fully comprehensible to readers.
VIII. AUTHOR ANONYMITY
It is the policy of Value in Health Regional Issues that peer review of
submitted manuscripts is double blinded, i.e., the reviewers do not know
the names of the authors of manuscripts and the authors do not know the
names of the reviewers. Blinded reviews are common practice at many
important scientific and medical journals.
IX. THE REVIEW PROCESS
All manuscripts deemed appropriate for Value in Health Regional Issues after
initial screening will be reviewed by at least two peer reviewers. The objec-
tive of the journal is to complete peer review and reach editorial decision
within ten to twelve weeks of submission, at which time the corresponding
author will receive written notification, including anonymous reviewer com-
mentary.
X. AUTHOR TRACKING SERVICES
Authors may track accepted manuscripts (English only) at:
http://www.elsevier.com/trackarticle and set up e-mail alerts to inform
them when an article’s status has changed. Contact details for questions
arising after acceptance of an manuscript, especially those relating to
proofs, will be provided by the publisher. For manuscripts not submitted in
English, authors may query the Value in Health Regional Issues Editorial
office at: vihriasia@ispor.org, vihrila@ispor.org, or vihriceewaa@ispor.org.
XI. PROOFS
Proofs are to be sent electronically to Authors to review for printer’s errors.
Substantive changes or additions to the edited manuscript cannot
be allowed at this stage. Corrected proofs should be returned to the
publisher within 2 days of receipt.
XII. OFFPRINTS
The corresponding author, at no cost, will be provided with a PDF file of
the article via e-mail. For an extra charge, paper offprints can be ordered
via the offprint order form which is sent once the manuscript is accepted
for publication. The PDF file is a watermarked version of the published
article and includes a cover sheet with the journal cover image and a
disclaimer outlining the terms and conditions of use.
